NanoGhost

NanoGhost is a pioneering biotechnology research company focused on developing innovative solutions in targeted drug delivery. Harnessing the homing nature of stem cells, NanoGhost is committed to advancing the treatment of oncological diseases through its highly selective drug delivery platform. Located at 12 Beni Ga’on st., Netanya, Israel, NanoGhost is dedicated to improving patient outcomes and transforming the landscape of cancer therapy.

NanoGhost’s novel and versatile platform utilizes the cell membrane of mesenchymal stem cells (MSCs) to create Nano-Ghosts (NGs), enabling selective penetration of tumors, including those in the brain (crossing the BBB) and pancreas. By loading NanoGhosts with various drug types, NanoGhost aims to significantly reduce tumor size and prolong survival, thereby enhancing the efficacy of cancer treatments. The company's innovative approach positions NanoGhost as a leader in the bio-convergence and nanotechnology fields.

NanoGhost continues to push the boundaries of biotechnology, focusing on delivering cutting-edge solutions for complex medical challenges. With its commitment to innovation and excellence, NanoGhost is poised to make a significant impact on the future of oncology. We invite the management team at NanoGhost to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.